Balchem reported a strong financial quarter with record-breaking performances across all segments and initiated strategic growth projects. Despite challenges such as increased operating expenses and tariff impacts, the company remains well-positioned for continued growth.

Company Guidance -

Q3 2025

During Balchem's second-quarter 2025 earnings call, the company provided robust guidance, highlighting record financial achievements. The company reported a 9.1% year-over-year increase in consolidated revenue, reaching $255 million. This growth was supported by performance across all segments, with Human Nutrition & Health contributing $161 million, Animal Nutrition & Health contributing $56 million, and Specialty Products adding $37 million in sales. Adjusted EBITDA reached a record $69 million, reflecting an 11.2% increase, and the adjusted EBITDA margin improved by 50 basis points to 27.1%. The company also reported record quarterly adjusted net earnings of $42 million, a 16.8% increase, translating to $1.27 per diluted share, up by $0.18 year-over-year. Balchem expressed optimism for continued growth in the second half of 2025, driven by strategic initiatives, market demand, and favorable macroeconomic conditions, including the European Commission's provisional antidumping duties on Chinese choline.

Record-Breaking Financial Performance

Balchem reported record quarterly consolidated revenue of $255 million, a 9.1% increase from the prior year. Adjusted EBITDA reached $69 million, up 11.2%, with an adjusted EBITDA margin of 27.1%, a 50 basis point improvement. Net income increased by 19.4% to $38 million.

Strong Segment Growth

All three reporting segments (Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products) experienced year-over-year sales and earnings growth, with Human Nutrition & Health segment achieving record sales of $161 million, an 8.7% increase.

Strategic Expansion Initiatives

Balchem announced plans to build a new $36 million manufacturing facility in New York to double its capacity for microencapsulation technologies, supporting continued growth.

Positive Impact of European Antidumping Duties

The European Commission's provisional antidumping duties on Chinese choline of 95% to 120% are expected to benefit Balchem's Animal Nutrition & Health segment.

Scientific Research and Innovations

Significant progress in the scientific pipeline with 20 active clinical studies and 9 published research studies, including findings on dietary choline reducing Alzheimer's risk by 51%.

Balchem (BCPC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BCPC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 24, 2025	2025 (Q3)	1.16 / -	1.03	―	―	―
Jul 31, 2025	2025 (Q2)	1.12 / 1.17	1.09	7.34% (+0.08)
Apr 24, 2025	2025 (Q1)	1.04 / 1.13	1.03	9.71% (+0.10)
Feb 21, 2025	2024 (Q4)	1.05 / 1.03	0.95	8.42% (+0.08)
Oct 25, 2024	2024 (Q3)	1.11 / 1.03	1.04	-0.96% (-0.01)
Jul 26, 2024	2024 (Q2)	1.03 / 1.09	1.06	2.83% (+0.03)
May 03, 2024	2024 (Q1)	0.98 / 1.03	0.94	9.57% (+0.09)
Feb 16, 2024	2023 (Q4)	0.93 / 0.95	0.94	1.06% (+0.01)
Oct 27, 2023	2023 (Q3)	0.97 / 1.04	1	4.00% (+0.04)
Jul 28, 2023	2023 (Q2)	0.84 / 1.06	1.07	-0.93% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BCPC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$152.09	$152.47	+0.25%
Apr 24, 2025	$158.31	$154.20	-2.60%
Feb 21, 2025	$161.34	$163.73	+1.48%
Oct 25, 2024	$165.30	$170.57	+3.19%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Balchem (BCPC) report earnings?

Balchem (BCPC) is schdueled to report earning on Oct 24, 2025, Before Open (Confirmed).

What is Balchem (BCPC) earnings time?

Balchem (BCPC) earnings time is at Oct 24, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BCPC EPS forecast?

BCPC EPS forecast for the fiscal quarter 2025 (Q3) is 1.16.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing